An official website of the United States government
Here's how you know
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
|
PMC Copyright Notice
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
In supplemental file S4 Fig, the labels for “controls” and “progressors” were switched. The corrected S4 Fig can be found here.
Supporting information
S4 Fig. Distribution of signature scores for the TRM5 and 3PR in the combined ACS training and test cohorts and the GC6–74 validation cohort.
Mann–Whitney test P values are shown for comparison of each signature on different progressor and nonprogressor samples run on the different SOMAscan assays. 3PR, 3-protein pair-ratio; ACS, Adolescent Cohort Study; GC6–74, Grand Challenges 6–74; SOMAscan; TRM5, TB Risk Model 5.
1.Penn-Nicholson A, Hraha T, Thompson EG, Sterling D, Mbandi SK, Wall KM, et al. (2019) Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study. PLoS Med
16(4): e1002781
10.1371/journal.pmed.1002781
[DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
S4 Fig. Distribution of signature scores for the TRM5 and 3PR in the combined ACS training and test cohorts and the GC6–74 validation cohort.
Mann–Whitney test P values are shown for comparison of each signature on different progressor and nonprogressor samples run on the different SOMAscan assays. 3PR, 3-protein pair-ratio; ACS, Adolescent Cohort Study; GC6–74, Grand Challenges 6–74; SOMAscan; TRM5, TB Risk Model 5.